PT3003327T - Polímeros de ligação de protões para administração oral - Google Patents

Polímeros de ligação de protões para administração oral

Info

Publication number
PT3003327T
PT3003327T PT147420012T PT14742001T PT3003327T PT 3003327 T PT3003327 T PT 3003327T PT 147420012 T PT147420012 T PT 147420012T PT 14742001 T PT14742001 T PT 14742001T PT 3003327 T PT3003327 T PT 3003327T
Authority
PT
Portugal
Prior art keywords
proton
oral administration
binding polymers
polymers
binding
Prior art date
Application number
PT147420012T
Other languages
English (en)
Inventor
Klaerner Gerrit
F Connor Eric
K Gbur Randi
J Kade Matthew
H Kierstead Paul
M Buysse Jerry
J Cope Michael
N Biyani Kalpesh
H Nguyen Son
M Tabakman Scott
Original Assignee
Tricida Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tricida Inc filed Critical Tricida Inc
Publication of PT3003327T publication Critical patent/PT3003327T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F226/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen
    • C08F226/02—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen by a single or double bond to nitrogen
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02—Polyamines
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02—Polyamines
    • C08G73/024—Polyamines containing oxygen in the form of ether bonds in the main chain
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/40—Concentrating samples
    • G01N1/4077—Concentrating samples by other techniques involving separation of suspended solids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/40—Concentrating samples
    • G01N1/4077—Concentrating samples by other techniques involving separation of suspended solids
    • G01N2001/4083—Concentrating samples by other techniques involving separation of suspended solids sedimentation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/40—Concentrating samples
    • G01N1/4077—Concentrating samples by other techniques involving separation of suspended solids
    • G01N2001/4088—Concentrating samples by other techniques involving separation of suspended solids filtration
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
PT147420012T 2013-06-05 2014-06-05 Polímeros de ligação de protões para administração oral PT3003327T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361831445P 2013-06-05 2013-06-05

Publications (1)

Publication Number Publication Date
PT3003327T true PT3003327T (pt) 2017-11-09

Family

ID=51212941

Family Applications (3)

Application Number Title Priority Date Filing Date
PT191692599T PT3578185T (pt) 2013-06-05 2014-06-05 Polímeros ligantes de protões para administração oral
PT17177221T PT3287133T (pt) 2013-06-05 2014-06-05 Polímeros ligantes de protões para administração oral
PT147420012T PT3003327T (pt) 2013-06-05 2014-06-05 Polímeros de ligação de protões para administração oral

Family Applications Before (2)

Application Number Title Priority Date Filing Date
PT191692599T PT3578185T (pt) 2013-06-05 2014-06-05 Polímeros ligantes de protões para administração oral
PT17177221T PT3287133T (pt) 2013-06-05 2014-06-05 Polímeros ligantes de protões para administração oral

Country Status (25)

Country Link
US (8) US9205107B2 (pt)
EP (4) EP3287133B1 (pt)
JP (4) JP6453860B2 (pt)
KR (4) KR20210131457A (pt)
CN (3) CN105377270B (pt)
AU (3) AU2014274817B2 (pt)
BR (1) BR112015030142B1 (pt)
CA (1) CA2912911C (pt)
CY (3) CY1119611T1 (pt)
DK (3) DK3287133T3 (pt)
ES (3) ES2733493T3 (pt)
HK (3) HK1222120A1 (pt)
HR (3) HRP20171590T1 (pt)
HU (3) HUE043999T2 (pt)
IL (3) IL242758B (pt)
LT (3) LT3003327T (pt)
MX (3) MX364785B (pt)
NO (1) NO2905572T3 (pt)
PL (2) PL3003327T3 (pt)
PT (3) PT3578185T (pt)
RS (2) RS59033B1 (pt)
RU (1) RU2728778C2 (pt)
SI (3) SI3578185T1 (pt)
TR (1) TR201909355T4 (pt)
WO (1) WO2014197725A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3287133T3 (da) 2013-06-05 2019-07-01 Tricida Inc Proton-bindende polymerer til oral indgivelse
PT3593808T (pt) * 2014-12-10 2021-02-11 Tricida Inc Polímeros de ligação a protões para administração oral
EP3452028A4 (en) * 2016-05-06 2020-04-15 Tricida Inc. COMPOSITIONS AND METHOD FOR TREATING ACID-BASED DISORDERS
CN110114389B (zh) 2016-12-28 2022-04-01 富士胶片株式会社 含氮原子的聚合物或其盐的乳化液、其制造方法、及粒子的制造方法
US10934380B1 (en) 2017-09-25 2021-03-02 Tricida, Inc. Crosslinked poly(allylamine) polymer pharmaceutical compositions
CN111225674A (zh) 2017-10-16 2020-06-02 富士胶片株式会社 高磷血症治疗剂
WO2019090176A1 (en) * 2017-11-03 2019-05-09 Tricida, Inc. Compositions for and method of treating acid-base disorders
EP3703707A4 (en) * 2017-11-03 2021-08-11 Tricida, Inc. METHOD FOR TREATMENT OF ACID-BASE DISORDER
WO2019236636A1 (en) * 2018-06-04 2019-12-12 Tricida, Inc. Method of treating acid-base disorders
EP3999593A1 (en) * 2019-07-19 2022-05-25 Acatechol, Inc. Molecularly well-defined antibiofouling and polyionic coatings
EP4053179A1 (en) 2021-03-01 2022-09-07 Tricida Inc. Crosslinked poly(allylamine) polymer pharmaceutical compositions
WO2023109825A1 (zh) * 2021-12-14 2023-06-22 上海石趣医药科技有限公司 氧化银和/或其水合物在制备药物中的用途
CN115260355A (zh) * 2022-05-16 2022-11-01 江苏中天药业有限公司 一种阴离子交换树脂、其制备方法、该树脂与药物的复合物和其掩味制剂
KR20230047972A (ko) 2023-03-21 2023-04-10 최문수 개인별 맞춤형 그립 형상이 형성된 운동기구용 손잡이

Family Cites Families (120)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6444221B1 (en) 1992-06-30 2002-09-03 Howard K. Shapiro Methods of treating chronic inflammatory diseases using carbonyl trapping agents
US20050090553A1 (en) 1992-06-30 2005-04-28 Shapiro Howard K. Compositions and method for treatment of chronic inflammatory diseases
US5534259A (en) * 1993-07-08 1996-07-09 Liposome Technology, Inc. Polymer compound and coated particle composition
US5496545A (en) 1993-08-11 1996-03-05 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
US5667775A (en) 1993-08-11 1997-09-16 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
US5648355A (en) 1994-02-09 1997-07-15 Kos Pharmaceutical, Inc. Method of treatment of endogenous, painful gastrointestinal conditions of non-inflammatory, non-ulcerative origin
TW474813B (en) 1994-06-10 2002-02-01 Geltex Pharma Inc Alkylated composition for removing bile salts from a patient
AU703842B2 (en) 1994-10-17 1999-04-01 Robert M. Bersin Compositions comprising carbonate/bicarbonate buffered dichloroacetic acid and methods for treatment of metabolic and cardiovascular disorders
US20020006899A1 (en) 1998-10-06 2002-01-17 Pospisilik Andrew J. Use of dipeptidyl peptidase IV effectors for lowering blood pressure in mammals
US5753706A (en) 1996-12-16 1998-05-19 Hsu; Chen Hsing Methods for treating renal failure
AUPO758297A0 (en) 1997-06-27 1997-07-24 Rowe, James Baber Control of acidic gut syndrome
US6726905B1 (en) 1997-11-05 2004-04-27 Genzyme Corporation Poly (diallylamines)-based phosphate binders
AU2682499A (en) 1998-02-17 1999-08-30 Dimitri R. Kioussis Anion binding polymers and the use thereof
US6485703B1 (en) 1998-07-31 2002-11-26 The Texas A&M University System Compositions and methods for analyte detection
US6271264B1 (en) 1998-12-01 2001-08-07 Geltex Pharmaceuticals, Inc. Polymers containing spirobicyclic ammonium moieties as bile acid sequestrants
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
GB9927088D0 (en) 1999-11-17 2000-01-12 Secr Defence Use of poly(diallylamine) polymers
AU2001241076A1 (en) 2000-03-09 2001-09-17 Hisamitsu Pharmaceutical Co. Inc. Crosslinked anion-exchange resin or salt thereof
WO2001066607A1 (fr) 2000-03-09 2001-09-13 Hisamitsu Pharmaceutical Co., Inc. Resine echangeuse d'anions reticulee ou sel de celle-ci et adsorbant phosphoreux la contenant
WO2001068106A1 (fr) 2000-03-13 2001-09-20 Hisamitsu Pharmaceutical Co., Inc. Prophylactiques et/ou remedes pour hyperphosphatemie
JP2002028737A (ja) 2000-07-07 2002-01-29 Fujitsu Ltd プレス打ち抜き加工方法及びプレス打ち抜き加工装置
JP2004528332A (ja) 2001-04-18 2004-09-16 ジェンザイム コーポレーション 痛風を治療する方法および尿酸を結合する方法
AU2002252632B2 (en) * 2001-04-18 2004-09-23 Genzyme Corporation Low salt forms of polyallylamine
TW200304813A (en) 2002-03-11 2003-10-16 Novartis Ag Salts of organic acid
EP1597276A4 (en) 2003-02-10 2006-11-29 Autogen Res Pty Ltd THERAPEUTIC MOLECULES
TWI335218B (en) 2003-02-19 2011-01-01 Panion & Bf Biotech Inc Ferric organic compounds, uses thereof and methods of making same
WO2007022435A2 (en) 2005-08-18 2007-02-22 Globoasia, Llc Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same
CN1540136A (zh) * 2003-10-27 2004-10-27 华东理工大学 一种评价微生物驱油能力的方法
US7459502B2 (en) * 2003-11-03 2008-12-02 Ilypsa, Inc. Pharmaceutical compositions comprising crosslinked polyamine polymers
US7449605B2 (en) 2003-11-03 2008-11-11 Ilypsa, Inc. Crosslinked amine polymers
US7608674B2 (en) * 2003-11-03 2009-10-27 Ilypsa, Inc. Pharmaceutical compositions comprising cross-linked small molecule amine polymers
US7767768B2 (en) 2003-11-03 2010-08-03 Ilypsa, Inc. Crosslinked amine polymers
US7385012B2 (en) * 2003-11-03 2008-06-10 Ilypsa, Inc. Polyamine polymers
US7335795B2 (en) 2004-03-22 2008-02-26 Ilypsa, Inc. Crosslinked amine polymers
WO2005065291A2 (en) 2003-12-31 2005-07-21 Genzyme Corporation Enteric coated aliphatic amine polymer bile acid sequestrants
CN1905901A (zh) 2004-01-29 2007-01-31 学校法人庆应义塾 红细胞功能修饰物质
AU2005228696B2 (en) 2004-03-30 2010-06-24 Relypsa, Inc. Methods and compositions for treatment of ion imbalances
US8192758B2 (en) 2004-03-30 2012-06-05 Relypsa, Inc. Ion binding compositions
US7854924B2 (en) 2004-03-30 2010-12-21 Relypsa, Inc. Methods and compositions for treatment of ion imbalances
US8282960B2 (en) 2004-03-30 2012-10-09 Relypsa, Inc. Ion binding compositions
US7556799B2 (en) 2004-03-30 2009-07-07 Relypsa, Inc. Ion binding polymers and uses thereof
US7429394B2 (en) 2004-03-30 2008-09-30 Relypsa, Inc. Ion binding compositions
US8399025B2 (en) 2004-06-04 2013-03-19 Board Of Regents, The University Of Texas System Polyamine modified particles
BRPI0513500C8 (pt) 2004-07-19 2022-06-14 Robert Johan Jozeph Hageman Uso de equivalentes de aspartato e composição nutricional ou farmacêutica
DE102004035808A1 (de) 2004-07-21 2006-03-16 Kasch, Helmut, Dr. Ammoniumsalze und Ammoniumsalz-Mineralsalzchlatrate als Transport- und Wirkform für pharmazeutische-medizinische und als Phasentransfermittel für chemische Anwendungen
US8569277B2 (en) 2004-08-11 2013-10-29 Palo Alto Investors Methods of treating a subject for a condition
US20070293429A1 (en) 2004-10-08 2007-12-20 Therapei Pharmaceuticals, Inc. Vasoactive Intestinal Polypeptide Compositions
US20080214440A1 (en) 2004-10-08 2008-09-04 Forbes Medi-Tech (Research), Inc. Vasoactive intestinal polypeptide compositions
CN101065409A (zh) * 2004-10-13 2007-10-31 伊立普萨公司 交联胺聚合物
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
ITME20040015A1 (it) 2004-12-07 2005-03-07 Vincenzo Savica Chewing gum, caramelle gommose, pastiglie, compresse a lento rilascio di chelanti fosfato e/o fosforo salivare e capsule a lento rilascio di chelanti fosfato e/o fosforo a livello gastroenterico.
AU2006264407B2 (en) 2005-07-04 2012-08-30 Ramu Krishnan Improved drug or pharmaceutical compounds and a preparation thereof
EP1951266A2 (en) 2005-09-02 2008-08-06 Genzyme Corporation Method for removing phosphate and polymer used therefore
WO2007038801A2 (en) 2005-09-30 2007-04-05 Ilypsa, Inc. Monovalent cation-binding compositions comprising core-shell particles having crosslinked poly-vinylic shells, and methods of use thereof
EP1928476A1 (en) * 2005-09-30 2008-06-11 Ilypsa, Inc. Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammal
CA2624112A1 (en) 2005-09-30 2007-04-05 Ilypsa, Inc. Methods for preparing core-shell composites having cross-linked shells and core-shell composites resulting therefrom
JP5246398B2 (ja) 2005-11-08 2013-07-24 味の素株式会社 麻酔覚醒促進剤
WO2007056405A2 (en) 2005-11-08 2007-05-18 Genzyme Corporation Magnesium-containing polymers for the treatment of hyperphosphatemia
ITMI20052461A1 (it) 2005-12-22 2007-06-23 Univ Degli Studi Milano Sistemi microparticellari per la somministrazione orale di sostanze biologicamente attive
RU2008136081A (ru) 2006-02-14 2010-03-20 Тева Фармасьютикл Индастриес Лтд. (Il) Фармацевтические составы с алифатическими аминными полимерами и способы их производства
EP2016114A2 (en) 2006-05-05 2009-01-21 Genzyme Corporation Amine condensation polymers as phosphate sequestrants
JP2009542653A (ja) 2006-07-05 2009-12-03 ジェンザイム コーポレーション リン酸塩過剰血症のための鉄（ｉｉ）含有治療剤
CN101541235A (zh) * 2006-07-18 2009-09-23 基酶有限公司 胺类树状物
EP2049014A2 (en) * 2006-07-18 2009-04-22 Genzyme Corporation Amine dendrimers
US8391873B2 (en) 2006-07-21 2013-03-05 Qualcomm Incorporated Systems and methods for coordinating supplementary services for voice telephone calls in a centralized fashion
CA2660029A1 (en) 2006-08-04 2008-02-07 Nastech Pharmaceutical Company Inc. Compositions for intranasal delivery of human insulin and uses thereof
KR20090051240A (ko) 2006-09-01 2009-05-21 유에스브이 리미티드 세벨라머 염산염의 제조방법 및 그의 제형
BRPI0716066A2 (pt) 2006-09-01 2013-09-17 Genzyme Corp composiÇço farmacÊutica, mÉtodo para tratar doenÇas, polÍmero de amina, rede polimÉrica, mÉtodo para preparar um polÍmero de amina, e, composto de amina
US7964182B2 (en) * 2006-09-01 2011-06-21 USV, Ltd Pharmaceutical compositions comprising phosphate-binding polymer
WO2008029949A1 (en) 2006-09-06 2008-03-13 Sucampo Ag Method and composition for promoting gastrointestinal bicarbonate secretion
JP2010504975A (ja) 2006-09-29 2010-02-18 ゲンズイメ コーポレーション アミドデンドリマー組成物
JP2010513271A (ja) 2006-12-14 2010-04-30 ゲンズイメ コーポレーション アミド−アミンポリマー組成物
WO2008103368A1 (en) * 2007-02-23 2008-08-28 Genzyme Corporation Amine polymer compositions
US20080207766A1 (en) 2007-02-27 2008-08-28 Agi Therapeutics Research Ltd. Methods and compositions for treating at least one upper gastrointestinal symptom
WO2008109095A1 (en) 2007-03-08 2008-09-12 Genzyme Corporation Sulfone polymer compositions
TWI445540B (zh) 2007-04-20 2014-07-21 Ajinomoto Kk 抗低體溫組成物
WO2008133954A1 (en) 2007-04-27 2008-11-06 Genzyme Corporation Amido-amine dendrimer compositions
WO2009005838A2 (en) 2007-07-02 2009-01-08 Cognate3 Llc Process for the preparation of a non-corrosive base solution and methods of using same
JPWO2009008480A1 (ja) * 2007-07-11 2010-09-09 東レ株式会社 架橋ポリアリルアミン又はその酸付加塩、及びその医薬用途
EP2016947A1 (en) 2007-07-17 2009-01-21 Chemo Ibérica, S.A. Novel one step process for preparing cross-linked poly(allylamine) polymers
WO2009023544A2 (en) 2007-08-10 2009-02-19 Ilypsa, Inc. Dosage unit anion-exchange polymer pharmaceutical compositions
US20090156647A1 (en) 2007-12-12 2009-06-18 Iovate T. & P. Inc. Method for maintaining physiological pH levels during intensive physical exercise
PA8807201A1 (es) 2007-12-14 2009-07-23 Genzyme Corp Composiciones farmaceuticas
WO2009078958A1 (en) 2007-12-14 2009-06-25 Genzyme Corporation Coated pharmaceutical compositions
WO2009097127A1 (en) 2008-01-31 2009-08-06 Genzyme Corporation Pharmaceutical compositions
EP2282729A1 (en) 2008-03-11 2011-02-16 Livionex Inc. Methods and compositions for treating inflammation and inflammation-related pathologies
CA2720865A1 (en) 2008-04-08 2009-10-15 Usv Limited Process for preparation of amine polymer salt
ES2380162T3 (es) 2008-04-11 2012-05-09 Gp Investimenti S.R.L. Dispositivo de uso manual para el tratamiento de tejido humano con ultrasonidos
US20110142952A1 (en) 2008-06-20 2011-06-16 Harris David J Pharmaceutical Compositions
DE102008030046A1 (de) 2008-06-25 2009-12-31 Ratiopharm Gmbh Kompaktiertes Polyallylamin-Polymer
US20100008988A1 (en) 2008-07-14 2010-01-14 Glenmark Generics, Ltd. Tablet compositions of amine polymers
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
WO2010022381A1 (en) 2008-08-22 2010-02-25 Relypsa, Inc. Treating hyperkalemia with crosslinked cation exchange polymers of improved physical properties
WO2010022380A2 (en) 2008-08-22 2010-02-25 Relypsa, Inc. Linear polyol stabilized polyfluoroacrylate compositions
CA2737452C (en) 2008-09-25 2018-05-22 Vive Nano Inc. Methods to produce polymer nanoparticles and formulations of active ingredients
WO2010035273A2 (en) 2008-09-29 2010-04-01 Intec Pharma Ltd. Novel gastroretentive delivery system
US20100113479A1 (en) 2008-10-30 2010-05-06 Anusuya Choudhury Process for the preparation of tri-substituted pyridine and tri-substituted pyrimidine derivatives useful as gdir agonists
US20100166861A1 (en) 2008-12-29 2010-07-01 Kelly Noel Lynch Pharmaceutical formulations of sevalamer, or salts thereof, and copovidone
WO2010086881A2 (en) 2009-01-22 2010-08-05 Usv Limited Pharmaceutical compositions comprising phosphate-binding polymer
US8945508B2 (en) 2009-10-13 2015-02-03 The Regents Of The University Of Michigan Dendrimer compositions and methods of synthesis
EA024699B1 (ru) 2009-10-22 2016-10-31 Синтон Б. В. Фармацевтическая таблетка с немедленным высвобождением, содержащая севеламера карбонат
KR20120103689A (ko) 2009-12-07 2012-09-19 아이언우드 파마슈티컬스, 인코포레이티드 위장 장애의 치료
ES2598500T3 (es) 2010-02-24 2017-01-27 Relypsa, Inc. Poliimidazoles para su uso como secuestrantes de ácidos biliares
EP2998329A3 (en) 2010-02-24 2016-04-06 Relypsa, Inc. Crosslinked polyvinylamine, polyallylamine, and polyethyleneimine for use as bile acid sequestrants
RU2417782C1 (ru) * 2010-03-03 2011-05-10 Федеральное государственное образовательное учреждение высшего профессионального образования "Белгородская государственная сельскохозяйственная академия" Способ лечения ацидоза рубца
IT1406068B1 (it) 2010-07-22 2014-02-06 Medestea Int Spa Polidesossiribonucleotidi (pdrn) per l'impiego nel trattamento di condizioni di acidosi e composizioni a base di polidesossiribonucleotidi per il suddetto impiego
WO2012027331A1 (en) 2010-08-27 2012-03-01 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
KR101238210B1 (ko) 2011-06-30 2013-03-04 엘지전자 주식회사 이동 단말기
US20130137772A1 (en) 2011-11-29 2013-05-30 Raymond J. Bergeron Hydroxypolyamine salts
BR112014032049A2 (pt) 2012-06-21 2017-07-25 Keryx Biopharmaceuticals Inc citrato férrico e suplemento de ferro oral
BR112015007749A2 (pt) 2012-10-08 2017-07-04 Relypsa Inc métodos para tratamento de hipertensão , de hipercaliemia , e de doença renal crônica.
DK3287133T3 (da) 2013-06-05 2019-07-01 Tricida Inc Proton-bindende polymerer til oral indgivelse
JP2016535780A (ja) 2013-11-04 2016-11-17 ケリク バイオファーマシューティカルス， インコーポレーテッド 慢性腎臓病患者の心不全を軽減するためのクエン酸第二鉄
PT3593808T (pt) 2014-12-10 2021-02-11 Tricida Inc Polímeros de ligação a protões para administração oral
EP3452028A4 (en) 2016-05-06 2020-04-15 Tricida Inc. COMPOSITIONS AND METHOD FOR TREATING ACID-BASED DISORDERS
WO2019090176A1 (en) 2017-11-03 2019-05-09 Tricida, Inc. Compositions for and method of treating acid-base disorders
EP3703707A4 (en) 2017-11-03 2021-08-11 Tricida, Inc. METHOD FOR TREATMENT OF ACID-BASE DISORDER
WO2019236639A1 (en) 2018-06-04 2019-12-12 Tricida, Inc. Method of treating acid-base disorders
WO2019236124A1 (en) 2018-06-04 2019-12-12 Tricida, Inc. Method of treating acid-base disorders
WO2019236636A1 (en) 2018-06-04 2019-12-12 Tricida, Inc. Method of treating acid-base disorders

Also Published As

Publication number Publication date
EP3287133A1 (en) 2018-02-28
IL278183A (en) 2020-11-30
HK1251151B (zh) 2020-04-24
JP6453860B2 (ja) 2019-01-16
CN111671767B (zh) 2024-03-08
JP2016520652A (ja) 2016-07-14
RS59033B1 (sr) 2019-08-30
RU2015155596A3 (pt) 2018-05-10
US20220096534A1 (en) 2022-03-31
BR112015030142A2 (pt) 2017-07-25
KR20230114326A (ko) 2023-08-01
CN111671766B (zh) 2024-03-08
MX2019005300A (es) 2019-08-12
AU2014274817B2 (en) 2019-05-23
SI3003327T1 (en) 2018-01-31
HK1222120A1 (zh) 2017-06-23
RU2728778C2 (ru) 2020-07-31
RS61005B1 (sr) 2020-11-30
DK3578185T3 (da) 2020-11-02
DK3003327T3 (en) 2017-10-23
MX364785B (es) 2019-05-07
US9205107B2 (en) 2015-12-08
JP2020203917A (ja) 2020-12-24
IL271932A (en) 2020-02-27
JP6759316B2 (ja) 2020-09-23
US20160074430A1 (en) 2016-03-17
KR20160041855A (ko) 2016-04-18
CN111671766A (zh) 2020-09-18
WO2014197725A1 (en) 2014-12-11
IL278183B (en) 2021-09-30
KR102318910B1 (ko) 2021-10-29
KR20210131457A (ko) 2021-11-02
MX2021013880A (es) 2022-06-02
HUE043999T2 (hu) 2019-09-30
HUE034836T2 (en) 2018-03-28
LT3003327T (lt) 2017-12-27
HRP20171590T1 (hr) 2017-12-29
AU2019275584B2 (en) 2021-10-21
EP3003327B1 (en) 2017-08-09
US10391118B2 (en) 2019-08-27
CA2912911C (en) 2023-10-03
JP2022107004A (ja) 2022-07-20
US10363268B2 (en) 2019-07-30
ES2733493T3 (es) 2019-11-29
PL3287133T3 (pl) 2019-10-31
US9925214B2 (en) 2018-03-27
JP2019065024A (ja) 2019-04-25
PT3578185T (pt) 2020-11-10
MX2015016527A (es) 2016-07-22
CY1123673T1 (el) 2022-03-24
HK1223288A1 (zh) 2017-07-28
US20190231812A1 (en) 2019-08-01
US10369169B1 (en) 2019-08-06
US20150056451A1 (en) 2015-02-26
AU2019219800B1 (en) 2019-09-19
KR20240023672A (ko) 2024-02-22
BR112015030142B1 (pt) 2023-03-07
CY1119611T1 (el) 2018-04-04
JP7075455B2 (ja) 2022-05-25
IL271932B (en) 2020-11-30
EP3812761A1 (en) 2021-04-28
HRP20201767T1 (hr) 2020-12-25
CN105377270A (zh) 2016-03-02
EP3578185A1 (en) 2019-12-11
DK3287133T3 (da) 2019-07-01
IL242758B (en) 2020-01-30
CN105377270B (zh) 2020-09-04
US20180280428A1 (en) 2018-10-04
US20190134075A1 (en) 2019-05-09
LT3287133T (lt) 2019-07-10
HUE051198T2 (hu) 2021-03-01
KR102633597B1 (ko) 2024-02-06
EP3578185B1 (en) 2020-08-05
CY1121801T1 (el) 2020-07-31
CA2912911A1 (en) 2014-12-11
US11197887B2 (en) 2021-12-14
EP3287133B1 (en) 2019-04-17
RU2015155596A (ru) 2017-07-18
CN111671767A (zh) 2020-09-18
US20200206260A1 (en) 2020-07-02
US20180015121A1 (en) 2018-01-18
EP3003327A1 (en) 2016-04-13
US9993500B2 (en) 2018-06-12
TR201909355T4 (tr) 2019-07-22
PT3287133T (pt) 2019-07-12
HRP20191074T1 (hr) 2019-09-20
NO2905572T3 (pt) 2017-12-16
ES2646271T3 (es) 2017-12-13
AU2019275584A1 (en) 2020-01-02
LT3578185T (lt) 2020-11-25
SI3287133T1 (sl) 2019-09-30
ES2834485T3 (es) 2021-06-17
SI3578185T1 (sl) 2021-01-29
PL3003327T3 (pl) 2018-02-28
AU2014274817A1 (en) 2015-12-24

Similar Documents

Publication Publication Date Title
IL278183B (en) Proton binding polymers for oral administration
IL246377A0 (en) Pharmaceutical preparations for oral administration
HRP20180684T1 (hr) Kombinacija lijekova
IL290729A (en) Proton binding polymers for oral administration
GB201305103D0 (en) An oral dosage form
GB2520315B (en) Oral Syringes
GB201316662D0 (en) Pharmaceutical Combination
GB201309971D0 (en) Oral medicines syringe